欧洲唐氏综合症市场 – 行业趋势和 2028 年预测

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Pharmaceutical Europe Down Syndrome Market
请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

欧洲唐氏综合症市场 – 行业趋势和 2028 年预测

  • Pharmaceutical
  • Published Report
  • Mar 2021
  • Europe
  • 350 页面
  • 桌子數： 238
  • 图号： 18
立即购买 立即购买

>欧洲唐氏综合症市场，按疾病类型（21 三体综合征、易位唐氏综合症、镶嵌性唐氏综合症）、治疗（诊断、治疗）、最终用户（医院、诊所、家庭护理环境、治疗中心等）、分销渠道（直接招标、零售销售、其他）、国家（德国、英国、法国、意大利、西班牙、俄罗斯、波兰、瑞士、荷兰、匈牙利、奥地利、挪威、爱尔兰、土耳其、立陶宛和欧洲其他地区）划分的行业趋势和预测到 2028 年

欧洲唐氏综合症市场市场分析和洞察：欧洲唐氏综合症市场

预计唐氏综合症市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2021 年至 2028 年的预测期内，该市场的复合年增长率为 13.78%，预计到 2028 年将达到 7.2512 亿美元。对疾病的认识不断提高和唐氏综合症患病率的上升是预测期内推动市场需求的主要驱动力。

技术进步和政府支持的增加是预测期内推动唐氏综合症市场需求的主要驱动力。

唐氏综合症是一种因细胞分裂异常而发生的遗传性疾病。细胞分裂异常会导致 21 号染色体的额外完整或部分拷贝的增加。额外的遗传物质的存在会导致人们的身体和发育变化，从而导致唐氏综合症。与唐氏综合症相关的最常见的遗传异常包括智力障碍，主要是儿童的学习障碍。

认知使这些人能够选择新的诊断方法以及先进的治疗方法，从而形成健康的生活方式。这意味着对疾病的认识不断提高，成为唐氏综合症市场增长的驱动力。并发症表明，任何特定治疗的缺乏都会限制唐氏综合症市场的增长。在唐氏综合症市场运营的市场参与者正在采取多项战略举措，有望在各个方面推动其业务，为唐氏综合症市场的增长提供机会。与产品发布相关的漫长审批时间对唐氏综合症市场的增长构成了挑战。

唐氏综合症市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和唐氏综合症市场情景，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您创建收入影响解决方案以实现您的预​​期目标。

欧洲唐氏综合症市场唐氏综合症市场范围和市场规模

唐氏综合症市场根据疾病类型、治疗、最终用户和分销渠道进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。

  • 根据疾病类型，唐氏综合征市场分为 21 三体综合征、易位唐氏综合征和嵌合性唐氏综合征。2021 年，21 三体综合征占据市场主导地位，因为 95% 以上的唐氏综合征病例都是 21 三体综合征。
  • 根据治疗方式，唐氏综合症市场分为诊断和治疗。2021 年，诊断领域占据市场主导地位，因为大多数父母都会进行产前检查以了解胎儿的状况。
  • 根据最终用户，唐氏综合症市场分为医院、诊所、家庭护理机构、治疗中心和其他。2021 年，医院部门占据市场主导地位，因为它们是产前检测的主要机构。
  • 根据分销渠道，唐氏综合症市场分为直接招标、零售和其他。2021 年，直接招标市场占据主导地位，因为它是医院和诊所购买诊断产品的主要方式。

唐氏综合症市场国家级分析

对唐氏综合症市场进行了分析，并按上述国家、疾病类型、治疗方法、最终用户和分销渠道提供了市场规模信息。

唐氏综合症市场报告涉及的国家包括德国、英国、法国、意大利、西班牙、俄罗斯、波兰、瑞士、荷兰、匈牙利、奥地利、挪威、爱尔兰、土耳其、立陶宛和欧洲其他地区。

预计欧洲将在预测期内以最高的复合年增长率增长，因为唐氏综合症的诊断在大多数国家都是常规检查。预计德国将在欧洲市场占据主导地位。德国是欧洲市场潜力巨大、对唐氏综合症诊断需求较高的领先国家之一。

报告的国家部分还提供了影响单个市场因素和国内市场法规变化，这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了欧洲品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。

政府支持力度加大、研发力度加大，推动唐氏综合症市场增长

唐氏综合症市场还为您提供了每个国家唐氏综合症行业增长的详细市场分析，包括唐氏综合症药物销售、唐氏综合症技术进步的影响以及监管环境的变化及其对唐氏综合症市场的支持。数据涵盖 2010 年至 2019 年的历史时期。

竞争格局和唐氏综合症市场份额分析

唐氏综合症市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对唐氏综合症市场的关注有关。

从事唐氏综合症业务的主要公司包括 F. Hoffmann-La Roche Ltd、PerkinElmer Inc.、Illumina, Inc.、Thermo Fisher Scientific Inc.、Myriad Genetics, Inc.、Abbott、Natera, Inc、AtilaBiosystems、Physio.co.uk、Novus Biologicals（Bio-Techne 的子公司）、Down Syndrome Cork（Down Syndrome Ireland 的一个分支）、Demeditec Diagnostics GmbH、Symbol、ASDclinic.co.uk 以及其他国内公司。DBMR 分析师了解竞争优势，并为每个竞争对手分别提供竞争分析。

全球各地的公司也发起了许多产品的推出和协议，这也加速了唐氏综合症市场的发展。

例如，

  • 2017 年 4 月，Illumina 公司在欧洲推出了 VeriSeq NIPT 解决方案。该产品是一种 CE-IVD 标记的下一代测序技术，用于筛查染色体异常，并被证明可在妊娠 10 周内提供有关染色体状态的准确信息。该产品的推出增强了该公司的产品组合，并使其能够在全球唐氏综合症市场中扎根。

市场参与者的合作、产品发布、业务扩展、奖励和认可、合资企业和其他策略正在增强公司在唐氏综合症市场的市场，这也为组织改善其对唐氏综合症的服务提供了好处。

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of EUROPE Down syndrome MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. treatment of Down syndrome LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. MARKET END USER COVERAGE GRID
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. Europe DOWN SYNDROME MARKET: Pipeline analysis
    1. PIPELINE PRODUCTS IMPACT ANALYSIS
    2. NNI-351
    3. ASPARAGINASE
    4. ANVS-401
    5. QUILLIVANT XR
    6. TOFACITINIB
    7. MEMANTINE HYDROCHLORIDE
    8. NICOTINE
    9. AEF0217
    10. ACI-24
  5. Europe DOwn syndrome Market: Laws and regulations
  6. Market Overview
    1. Drivers
      1. increasing prevalence OF DOWN syndrome
      2. rising demand of effective therapies
      3. rising awareness about the diseasE
      4. technological ADVANCEMENTS
      5. increasing government support
    2. RESTRAINTS
      1. UNAVAILABILITY OF any specific treatment
      2. Side Effects Associated With Down Syndrome Treatment Therapies
      3. high cost of diagnosis
    3. opportunities
      1. STRATEGIC INITIATIVES BY MARKET PLAYERS
      2. increasing research and development
      3. presence of pipeline therapies
      4. presence of reimbursement
    4. challenGes
      1. Lack of Skilled Proffessionals
      2. Long Process for Product Launch
      3. Transfer of COVID-19 Infections by Diagnostic Methods
  7. Impact of COVID-19 on Europe Down Syndrome Market
    1. Price Impact
    2. Impact on Supply Chain
    3. Impact on Demand
    4. Strategic Decisions for Manufacturers
    5. Conclusion
  8. Europe Down syndrome MARKET, BY disease Type
    1. overview
    2. trisomy 21
    3. translocation Down syndrome
    4. mosaic Down syndrome
  9. Europe Down syndrome MARKET, BY treatment
    1. overview
    2. diagnosis
      1. Screening Tests
        1. First Trimester
          1. Blood Test
          2. Nuchal Translucency Testing
        2. Integrated Screening Test
          1. First Trimester
          2. Second Trimester
        3. The Triple Screen or Quadraple Screen Test
        4. Ultrasound
        5. Cell Free DNA
      2. Diagnostic Tests
        1. Chronic Villus Sampling
        2. Amniocentesis
        3. Precutaneous Umbical Cord Sampling
    3. therapy
      1. Early Intervention Therapy
        1. Speech-Language Therapy
        2. Physical Therapy
        3. Occupational Therapy
        4. Others
      2. Assistive Technology
        1. Hearing Aids
        2. Glasses
        3. Others
      3. Surgery
        1. Atrioventricular Septal Defect (AVSD)
        2. Duodenal Atresia
        3. Others
      4. Others
  10. Europe Down syndrome MARKET, BY end user
    1. overview
    2. hospital
    3. clinics
    4. homecare setting
    5. others
  11. Europe Down syndrome MARKET, BY distribution channel
    1. overview
    2. direct tender
    3. retail sales
    4. others
  12. EUROPE Down syndrome MARKET, by Geography
    1. europe
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Russia
      7. Poland
      8. Switzerland
      9. Netherlands
      10. Hungary
      11. Austria
      12. Norway
      13. Ireland
      14. Turkey
      15. Lithuania
      16. Rest of Europe
  13. Europe Down syndrome market: COMPANY landscape
    1. company share analysis: Europe
  14. company profile
    1. F. Hoffmann-La Roche Ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. Company ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. PerkinElmer Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. Illumina, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    4. Thermo Fisher Scientific Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    5. Myriad Genetics, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    6. Abbott
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    7. Abnova Corporation
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. ASDclinic.co.uk
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENT
    9. AtilaBiosystems
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    10. Boston Children's Hospital
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    11. Boys Town National Research Hospital
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    12. Children's Hospital Colorado
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    13. Demeditec Diagnostics GmbH
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    14. Down Syndrome Cork
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    15. Mayo Clinic Health System
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    16. Natera, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    17. Next Biosciences
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    18. Novus Biologicals (A Subsidiary of Bio-Techne)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    19. Kid Sense Child Development Corporation Pty Ltd
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENT
    20. Physio.co.uk.
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENT
    21. Symbol
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENT
  15. questionnaire
  16. related reports

表格列表

TABLE 1 Europe Down syndrome market: Pipeline Analysis

TABLE 2 REGULATION imposed by several regulatory agencies in different regions

TABLE 3 Europe Down Syndrome Market, By Disease Type, 2019-2028 (USD Million)

TABLE 4 Europe Trisomy 21 in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 5 Europe Translocation Down Syndrome in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 6 Europe Mosaic Down Syndrome in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 7 Europe Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 8 Europe Diagnosis in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 9 Europe Diagnosis in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 10 Europe Diagnosis in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 11 Europe First Trimester in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 12 Europe Integrated Screening Test in Diagnosis in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 13 Europe Diagnostic Tests in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 14 Europe Therapy in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 15 Europe Therapy in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 16 Europe Early Intervention Therapy in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 17 Europe Assistive Technology in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 18 Europe Surgery in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 19 Europe Therapy in Down Syndrom Market, By End User, 2019-2028 (USD Million)

TABLE 20 Europe Hospital in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 21 Europe Clinics in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 22 Europe Homecare Setting in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 23 Europe Therapy Centers in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 24 Europe Others in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 25 Europe Down Syndrome Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 26 Europe Direct Tender in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 27 Europe Retail Sales in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 28 Europe Others in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 29 europe Down syndrome Market, By Country, 2019-2028 (USD Million)

TABLE 30 europe Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 31 europe Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 32 europe diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 33 europe screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 34 europe first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 35 europe integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 36 europe diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 37 europe therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 38 europe early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 39 europe assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 40 europe surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 41 europe Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 42 europe Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 43 germany Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 44 germany Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 45 germany diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 46 germany screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 47 germany first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 48 germany integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 49 germany diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 50 germany therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 51 germany early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 52 germany assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 53 germany surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 54 germany Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 55 germany Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 56 U.K. Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 57 U.K. Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 58 U.K. diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 59 U.K. screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 60 U.K. first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 61 U.K. integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 62 U.K. diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 63 U.K. therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 64 U.K. early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 65 U.K. assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 66 U.K. surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 67 U.K. Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 68 U.K. Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 69 france Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 70 france Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 71 france diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 72 france screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 73 france first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 74 france integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 75 france diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 76 france therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 77 france early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 78 france assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 79 france surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 80 france Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 81 france Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 82 italy Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 83 italy Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 84 italy diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 85 italy screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 86 italy first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 87 italy integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 88 italy diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 89 italy therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 90 italy early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 91 italy assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 92 italy surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 93 italy Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 94 italy Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 95 spain Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 96 spain Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 97 spain diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 98 spain screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 99 spain first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 100 spain integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 101 spain diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 102 spain therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 103 spain early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 104 spain assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 105 spain surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 106 spain Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 107 spain Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 108 russia Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 109 russia Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 110 russia diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 111 russia screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 112 russia first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 113 russia integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 114 russia diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 115 russia therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 116 russia early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 117 russia assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 118 russia surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 119 russia Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 120 russia Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 121 poland Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 122 poland Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 123 poland diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 124 poland screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 125 poland first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 126 poland integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 127 poland diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 128 poland therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 129 poland early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 130 poland assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 131 poland surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 132 poland Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 133 poland Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 134 switzerland Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 135 switzerland Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 136 switzerland diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 137 switzerland screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 138 switzerland first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 139 switzerland integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 140 switzerland diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 141 switzerland therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 142 switzerland early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 143 switzerland assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 144 switzerland surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 145 switzerland Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 146 switzerland Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 147 netherlands Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 148 netherlands Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 149 netherlands diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 150 netherlands screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 151 netherlands first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 152 netherlands integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 153 netherlands diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 154 netherlands therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 155 netherlands early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 156 netherlands assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 157 netherlands surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 158 netherlands Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 159 netherlands Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 160 hungary Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 161 hungary Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 162 hungary diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 163 hungary screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 164 hungary first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 165 hungary integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 166 hungary diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 167 hungary therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 168 hungary early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 169 hungary assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 170 hungary surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 171 hungary Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 172 hungary Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 173 austria Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 174 austria Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 175 austria diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 176 austria screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 177 austria first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 178 austria integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 179 austria diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 180 austria therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 181 austria early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 182 austria assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 183 austria surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 184 austria Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 185 austria Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 186 norway Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 187 norway Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 188 norway diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 189 norway screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 190 norway first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 191 norway integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 192 norway diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 193 norway therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 194 norway early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 195 norway assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 196 norway surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 197 norway Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 198 norway Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 199 ireland Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 200 ireland Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 201 ireland diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 202 ireland screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 203 ireland first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 204 ireland integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 205 ireland diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 206 ireland therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 207 ireland early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 208 ireland assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 209 ireland surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 210 ireland Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 211 ireland Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 212 turkey Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 213 turkey Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 214 turkey diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 215 turkey screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 216 turkey first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 217 turkey integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 218 turkey diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 219 turkey therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 220 turkey early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 221 turkey assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 222 turkey surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 223 turkey Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 224 turkey Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 225 lithuania Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 226 lithuania Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 227 lithuania diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 228 lithuania screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 229 lithuania first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 230 lithuania integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 231 lithuania diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 232 lithuania therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 233 lithuania early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 234 lithuania assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 235 lithuania surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 236 lithuania Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 237 lithuania Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 238 rest of europe Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

图片列表

FIGURE 1 Europe DOWN SYNDROME MARKET: SEGMENTATION

FIGURE 2 EUROPE DOWN SYNDROME MARKET : DATA TRIANGULATION

FIGURE 3 Europe Down syndrome Market: DROC ANALYSIS

FIGURE 4 Europe Down syndrome market: Europe VS. REGIONAL MARKET ANALYSIS

FIGURE 5 Europe Down syndrome Market: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE Down syndrome MARKET: MULTIVARIATE MODELLING

FIGURE 7 EUROPE Down syndrome MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE DOWN SYNDROME MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE down syndrome Market: MARKET END UsER COVERAGE GRID

FIGURE 10 EUROPE DOWN SYNDROME MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 Europe Down syndrome market: SEGMENTATION

FIGURE 12 Increasing PREVALENCE of Down syndrome and Other Related Disorders and Rising Demand for Effective therapies is DRIVing THE Europe Down syndrome MARKET IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 trisomy 21 SEGMENT is expected to account for the largest share of the Europe DOWN SYNDROME MARKET in 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGEs OF EUROPE Down syndrome market

FIGURE 15 Europe Down syndrome market: BY disease type, 2020

FIGURE 16 Europe Down syndrome market: BY disease type, 2020-2028 (USD Million)

FIGURE 17 Europe Down syndrome market: BY disease type, CAGR (2020-2028)

FIGURE 18 Europe Down syndrome market: BY disease type, LIFELINE CURVE

FIGURE 1 Europe Down syndrome market: BY treatment, 2020

FIGURE 2 Europe Down syndrome market: BY treatment, 2020-2028 (USD Million).

FIGURE 3 Europe Down syndrome market: BY treatment, CAGR (2020-2028)

FIGURE 4 Europe Down syndrome market: BY treatment, LIFELINE CURVE

FIGURE 5 Europe Down syndrome market: BY end user, 2020

FIGURE 6 Europe Down syndrome market: BY end user, 2020-2028 (USD Million)

FIGURE 7 Europe Down syndrome market: BY end user, CAGR (2020-2028)

FIGURE 8 Europe Down syndrome market: BY end user, LIFELINE CURVE

FIGURE 9 Europe Down syndrome market: BY distribution channel, 2020

FIGURE 10 Europe Down syndrome market: BY distribution channel, 2020-2028 (USD Million)

FIGURE 11 Europe Down syndrome market: BY distribution channel, CAGR (2020-2028)

FIGURE 12 Europe Down syndrome market: BY distribution channel, LIFELINE CURVE

FIGURE 13 europe Down syndrome market: SNAPSHOT (2020)

FIGURE 14 europe Down syndrome market: BY COUNTRY (2020)

FIGURE 15 europe Down syndrome market: BY COUNTRY (2021 & 2028)

FIGURE 16 europe Down syndrome market: BY COUNTRY (2021 & 2028)

FIGURE 17 europe Down syndrome market: BY treatment (2021-2028)

FIGURE 18 Europe Down syndrome market: company share 2020 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

浏览相关页面

Banner